US FDA Seeks Ability To Include More Inactive Ingredient, Excipient Info In Brand Labeling

 
• By Derrick Gingery
  
Squeegee clears window with clouds
The FDA wants to provide a clearer picture of the inactive ingredients and excipients used in brand drugs to streamline generic development. • Source: Alamy

More from Generics

More from Biosimilars & Generics